Columbus, OH, United States of America

Chih-Yun Johnny Tu


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1988-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chih-Yun Johnny Tu: Innovator in Antiemetic Agents

Introduction

Chih-Yun Johnny Tu is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods to control emesis caused by chemotherapeutic agents. With a total of 2 patents, his work has the potential to improve the quality of life for patients undergoing chemotherapy.

Latest Patents

Tu's latest patents include innovative methods for alleviating emesis associated with chemotherapy. One of his patents describes a method that involves administering an antiemetic agent or a pharmaceutically acceptable salt thereof to patients alongside chemotherapeutic agents. The antiemetic agent is characterized by a specific formula that includes various substituents and structural components designed to effectively alleviate nausea and vomiting caused by chemotherapy.

Career Highlights

Throughout his career, Chih-Yun Johnny Tu has worked with reputable companies such as Erbamont Inc. and Pharmacia Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Tu has collaborated with various professionals in his field, including his coworker Jung-Hui Sun. These collaborations have likely enhanced his research and development efforts in creating effective antiemetic solutions.

Conclusion

Chih-Yun Johnny Tu's contributions to the pharmaceutical industry, particularly in the area of antiemetic agents, demonstrate his commitment to improving patient care. His innovative methods and patents reflect his dedication to addressing the challenges faced by chemotherapy patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…